Client’s Testimonial:
“This is excellent news. Thank you very much. I have always been impressed by the promptness and high degree of professionalism I have seen with your firm. I have already recommended your firm to a few of my friends... I am glad that I made the right decision in choosing your firm. Thank you again.”
On January 27th, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Visiting Scientist/Associate Research Scientist in the Field of Nanotechnology (Approval Notice).
General Field: Nanotechnology
Position at the Time of Case Filing: Visiting Scientist/Associate Research Scientist
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Massachusetts
Processing Time: 8 days (Premium Processing requested)
Case Summary:
North America Immigration Law Group recently filed an EB-1A (Alien of Extraordinary Ability) petition on behalf of a client who obtained his Ph.D. from an institution in his birth country of India. Our client’s education background, research experience, and dual roles as a visiting scientist and associate research scientist made him well-suited for filing his I-140 under EB-1A. As he chose the Premium Processing option, he received an approval notice just eight days later.
In our presentation to the USCIS, North America Immigration Law Group meticulously highlighted our client’s professional achievements, specifically his nanoparticles-based formulations to study, diagnose, and treat major diseases. We established that his findings, which feature multiple medical applications – such as combining chemotherapy and radiation therapy using a single implant – are beneficial to the United States. Furthermore, we detailed his outstanding professional record. This was comprised of his nearly 3000 independent citations, his 48 published papers, and his experience conducting 70 peer reviews. We also included several recommendation letters contributed by other prominent nanotechnologists, one of whom wrote, “[Client] is one such scientist who has worked within the field of nanotechnology to develop nanoparticles for the delivery of anti-cancer drugs to tumors specifically. He has been immensely successful in these efforts and the result has been a great improvement in nanomedicine, which is leading to the betterment of patients' lives.”
We join our client in celebrating the approval of his EB-1A petition, and we wish him well in his future investigations in the field of nanotechnology.